30.04.2024 - TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has signed a non-exclusive License and Supply Agreement with Lonza, a global development and manufacturing .
SAN DIEGO, April 30, 2024 TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
Oligonucleotide Synthesis Market Worth $19 7 billion finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Maravai LifeSciences (NASDAQ:MRVI) Shares Up 8 1% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) traded down 2.9% on Wednesday . The company traded as low as $7.81 and last traded at $7.90. 268,444 shares traded hands during mid-day trading, a decline of 90% from the average session volume of 2,618,730 shares. The stock had previously closed at $8.14. Analyst Upgrades […]